Clinical Trials in Barcelona, Barcelona
239 recruiting
Showing 1–20 of 149 trials
Recruiting
Phase 3
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.
Lung Diseases
Fundación GECP129 enrolled30 locationsNCT06431633
Recruiting
Phase 2
Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
Fundación GECP19 enrolled20 locationsNCT05398094
Recruiting
Not Applicable
Improving the Treatment of Anorexia Nervosa in Children Through Virtual Reality Body Exposure
Anorexia Nervosa
University of Barcelona108 enrolled1 locationNCT06166355
Recruiting
Phase 2
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc310 enrolled91 locationsNCT05128825
Recruiting
Phase 2
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Non-obstructive Hypertrophic Cardiomyopathy
Imbria Pharmaceuticals, Inc.165 enrolled56 locationsNCT07023614
Recruiting
Phase 1
Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma
Pancreatic Adenocarcinoma
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)15 enrolled26 locationsNCT06892054
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
GM1 GangliosidosisGM2 GangliosidosisNiemann-Pick Type C Disease
Azafaros A.G.147 enrolled37 locationsNCT07054515
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)
Niemann-Pick Type C Disease
Azafaros A.G.72 enrolled34 locationsNCT07082725
Recruiting
Phase 3
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Clostridium Difficile Infection RecurrenceClostridium DifficileClostridioides Difficile Infection+7 more
Vedanta Biosciences, Inc.852 enrolled215 locationsNCT06237452
Recruiting
Thoracic Tumours Register
Thoracic Tumors
Spanish Lung Cancer Group10,000 enrolled79 locationsNCT02941458
Recruiting
Phase 2
Oxytocin Plus Self-compassion Training in Borderline Personality Disorder
Self-compassion Training (SCT) Plus Intranasal OxytocinSelf-compassion Training (SCT) Plus Intranasal Placebo
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau80 enrolled1 locationNCT07551882
Recruiting
Phase 3
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
MASH - Metabolic Dysfunction-Associated SteatohepatitisNASH - Nonalcoholic Steatohepatitis
Akero Therapeutics, Inc2,150 enrolled318 locationsNCT06528314
Recruiting
Phase 3
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis
Gangliosidoses, GM2Gangliosidosis, GM1
Azafaros A.G.75 enrolled36 locationsNCT07082543
Recruiting
Not Applicable
PVI vs ESP Block for Reducing Bleeding and Postoperative Pain in Lumbar Fusion Surgery.
Postoperative PainSurgical Blood LossLumbar Spinal Fusion Surgery
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau62 enrolled2 locationsNCT07550114
Recruiting
Morphometric Study of the Female Pelvic and Lower Abdominal Retroperitoneum in Cadavers
Pelvic AnatomyRetroperitoneumCadaveric Study+1 more
Hospital Universitari de Bellvitge20 enrolled2 locationsNCT07522931
Recruiting
Not Applicable
ARTIDIS Nanomechanical Generated Measurements for Early Breast Lesions
Breast Cancer
ARTIDIS AG2,706 enrolled5 locationsNCT06085833
Recruiting
Phase 1Phase 2
Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology
B-cell Lymphoma RecurrentRefractory B-Cell Lymphoma
Instituto de Investigación Biomédica de Salamanca27 enrolled8 locationsNCT06378190
Recruiting
Phase 3
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Breast CancerMetastatic Breast CancerER Positive Breast Cancer+1 more
Olema Pharmaceuticals, Inc.1,000 enrolled85 locationsNCT07085767
Recruiting
Phase 1
First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers
Lynch Syndrome
Fundacion Clinic per a la Recerca Biomédica20 enrolled1 locationNCT07163403
Recruiting
Phase 2
A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Genmab496 enrolled75 locationsNCT05283720